• Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • News from our Member Associations
    • Business & Policies
    • EU Focus
    • Regulatory Affairs
    • Sustainability & Environment
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us
Login Area

Members Area

 

Follow Us
Facebook
Twitter
LinkedIn
YouTube
Slideshare
EIPG Logo
  • Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • News from our Member Associations
    • Business & Policies
    • EU Focus
    • Regulatory Affairs
    • Sustainability & Environment
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us

Browsing Tag

rare diseases

5 posts

The first report on the implementation of the HTA regulation

One year after the HTA Regulation came into force, the HTA Coordination Group published its first report on activities carried out in 2025, including Joint Clinical Assessments and Joint Scientific Consultations.

Lessons learnt to transition from Horizon 2020 to the new FP10

by Giuliana Miglierini The European Commission published the ex post evaluation of Horizon 2020 (H2020), the FP8 framework…

The EU Commission proposal of the new pharmaceutical legislation

By Giuliana Miglierini After a five-months delay, the European Commission has announced on 26 April 2023 its proposal…

The main contributions to the consultation on the revision of the pharmaceutical legislation

by Giuliana Miglierini The European Commission has published the summary of the outcomes of the public consultation on…

Consultation on the reform of the European pharmaceutical legislation

by Giuliana Miglierini A new step in the review of the overall framework governing the pharmaceutical sector has…
EU Transparency Register
EIPG is registered in the EU
Transparency Register with public ID
number 979567925318-36

0
0
0
32
0
Disclaimer and Privacy Policy
  • Privacy Policy
  • Disclaimer
Contacts
  • General Inquiries
  • President
  • Executive Director
  • Vice-President Communications
  • News from our Member Associations